Art

J-GLOBAL ID：201902273981001641   Reference number：19A2078695

Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy

腫瘍長軸直径とSUVmaxは90Y-イブリツモマブチウキセタン単独療法における長期応答者を予測する

Author (19)： Tsukamoto Norifumi (Oncology Center, Gunma University Hospital, Maebashi, Gunma, Japan) ,  Tsukamoto Norifumi (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Yokohama Akihiko (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Yokohama Akihiko (Transfusion Service, Gunma University Hospital, Maebashi, Japan) ,  Higuchi Tetsuya (Department of Diagnostic Radiology and Nuclear Medicine, University Graduate School of Medicine, Maebashi, Japan) ,  Mitsui Takeki (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Koiso Hiromi (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Takizawa Makiko (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Shimizu Hiroaki (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Ishizaki Takuma (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Matsumoto Morio (Department of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan) ,  Toyama Kohtaro (Division of Internal Medicine, Fujioka General Hospital, Fujioka, Japan) ,  Sakura Tohru (Division of Internal Medicine, Saiseikai Maebashi Hospital, Maebashi, Japan) ,  Ogura Hidemi (Division of Internal Medicine, Maebashi Red Cross Hospital, Maebashi, Japan) ,  Saitoh Takayuki (Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Japan) ,  Ishida Fumihiro (Department of Biomedical Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan) ,  Murakami Hirokazu (Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Japan) ,  Tsushima Yoshito (Department of Diagnostic Radiology and Nuclear Medicine, University Graduate School of Medicine, Maebashi, Japan) ,  Handa Hiroshi (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan)
Material： International Journal of Hematology  (Int J Hematol)
Volume： 109  Issue： 1  Page： 91-97  Publication year： Jan. 2019 
JST Material Number： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *90Y-labeled anti-CD20 antibody ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2078695&from=J-GLOBAL&jstjournalNo=F0888A") }}

Author keywords (4)： Indolent lymphoma ,  90Y-ibritumomab tiuxetan ,  Tumor diameter ,  FDG-PET

JST classification (4)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Clinical application of radiopharmaceuticals  (GW18020Z)

Terms in the title (8)： 腫瘍 ,  直径 ,  SUVmax ,  イブリツモマブチウキセタン ,  単独療法 ,  長期 ,  応答 ,  予測